Handok and Genexine invested $25M USD in Rezolute in the U.S. to become the largest shareholder
Rezolute, a biopharmaceutical company specialized in the development of innovative drug therapies for metabolic and orphan diseases, Handok and Genexine, securing experience in bio pharmaceuticals development of Rezolute and establishing a bridgehead for U.S. market through open innovation On January 7th, Handok (Chairma..2019.01.08
[Arirang NEWS] S. Korea’s “hangover cure” industry booming as new products make waves in ma..
New types of ‘hangover cure’ products are popping up in S.Korea.2018.12.21
Handok signs contract with Pfizer Pharmaceutical Korea to sell Viviant and DUAVIVE in Korea
Handok signed a sales contract with Pfizer Pharmaceutical Korea (Country Manager: Dongwook Oh) to sell in Korea the postmenopausal osteoporosis drugs Viviant and DUAVIVE, used for the treatment of moderate-to-severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis. Hand..2018.12.18